search
Back to results

Use of a Hypertension Tool to Manage Blood Pressure in Hemodialysis

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Hypertension tool
Sponsored by
University Health Network, Toronto
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • ≥ 18 years of age
  • Receiving in-centre HD for at least 3 months
  • Considered hypertensive based on a median intradialytic blood pressure ≥ 140/90 mmgHG

Exclusion Criteria:

  • Are unable to provide informed consent
  • Are deemed medically unstable by the primary physician

Sites / Locations

  • Toronto General Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Implementation group

Control group

Arm Description

This group will have the hypertension tool implemented on them.

This group will not have the tool implemented.

Outcomes

Primary Outcome Measures

Blood pressure

Secondary Outcome Measures

Full Information

First Posted
March 20, 2017
Last Updated
April 30, 2021
Sponsor
University Health Network, Toronto
search

1. Study Identification

Unique Protocol Identification Number
NCT03089385
Brief Title
Use of a Hypertension Tool to Manage Blood Pressure in Hemodialysis
Official Title
Development, Validation, and Implementation of a Clinical Decision Tool for Blood Pressure Management in Patients on Hemodialysis
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
February 22, 2016 (Actual)
Primary Completion Date
April 9, 2021 (Actual)
Study Completion Date
April 9, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Health Network, Toronto

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The objective of this project is to develop, validate, and implement a tool to help manager hypertension in patients on hemodialysis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
38 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Implementation group
Arm Type
Experimental
Arm Description
This group will have the hypertension tool implemented on them.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
This group will not have the tool implemented.
Intervention Type
Other
Intervention Name(s)
Hypertension tool
Intervention Description
An algorithm developed by staff at UHN to help manage hypertension in hemodialysis patients.
Primary Outcome Measure Information:
Title
Blood pressure
Time Frame
3 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: ≥ 18 years of age Receiving in-centre HD for at least 3 months Considered hypertensive based on a median intradialytic blood pressure ≥ 140/90 mmgHG Exclusion Criteria: Are unable to provide informed consent Are deemed medically unstable by the primary physician
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marisa Battistella
Organizational Affiliation
University Health Network, Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
Toronto General Hospital
City
Toronto
State/Province
Ontario
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Use of a Hypertension Tool to Manage Blood Pressure in Hemodialysis

We'll reach out to this number within 24 hrs